PPARG and colorectal cancer: These biomolecular characteristics of anoikis align with previous findings by Terasaki et al. in DLD-1 human colorectal cancer cells treated with fucoxanthinol and by Schafer et al. in Hep3B cells using PPAR-γ inhibitors [27,32].